Ted H. Wojno


Dr. Wojno is a board certified ophthalmologist with sought-after expertise in oculoplastics and the treatment of tumors of the eyelids, tear ducts, and orbit.

Titles and Roles

James and Shirley Kuse Professor, Ophthalmology
Emory University School of Medicine
Director, Oculoplastics and Orbital Surgery
The Emory Clinic


Dr. Wojno began practicing with Emory Healthcare in 1985.  He treats adults and children with disorders of the eyelids, tear ducts, and eye sockets.  In 1986, he co-authored the original paper on the clinical use of Botox and maintains an active practice in cosmetic surgery, Botox injections and reconstruction of the periocular structures, tear duct surgery and orbital tumors.  In his career at Emory, he has directly trained all oculoplastics fellows within the Emory Eye Center's fellowship program.  He is a member of numerous medical associations including American Academy of Ophthalmology, the American Medical Association, and the American Society of Ophthalmic Plastic and Reconstructive Surgery, among others.


Dr. Wojno attended medical school at Wayne State University and completed his internship at William Beaumont Hospital and his residency at the Medial College of Wisconsin.  Dr. Wojno completed his fellowship at Bascom Palmer Eye Institute in Miami.


Dr. Wojno has received the Achievement Award of the American Academy of Ophthalmology, the Clinical Teaching Award from Emory Residents, and the Merrill Reeh Pathology Award from ASOPRS.


Dr. Wojno’s clinical research focuses include essential blepharospasm and orbital tumors


Dr. Wojno is the author or co-author of more than 80 articles in medical journals including Ophthalmology Plastic Reconstructive Surgery, Ophthalmology, Cornea, Otolaryngology Head Neck Surgery, American Journal of Rhinology, Laryngoscope, and the American Journal of Surgical Pathology.  He has contributed numerous book chapters and edited books on oculoplastics topics.  Dr. Wojno has made more than 100 presentations at regional and national meetings over the past 30 years.

Cascade Link